Filing Details

Accession Number:
0001062993-22-024356
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-21 19:28:36
Reporting Period:
2022-12-19
Accepted Time:
2022-12-21 19:28:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267565 Collegium Pharmaceutical Inc COLL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1448914 Thomas Michael Heffernan C/O Collegium Pharmaceutical, Inc.
100 Technology Center Drive
Stoughton MA 02072
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-19 3,606 $16.15 31,629 No 4 M Direct
Common Stock Disposition 2022-12-19 3,606 $23.04 28,023 No 4 S Direct
Common Stock Acquisiton 2022-12-20 33,758 $16.15 61,781 No 4 M Direct
Common Stock Disposition 2022-12-20 33,758 $23.08 28,023 No 4 S Direct
Common Stock Acquisiton 2022-12-21 46,600 $16.15 74,623 No 4 M Direct
Common Stock Disposition 2022-12-21 46,600 $23.11 28,023 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Purchase) Disposition 2022-12-19 3,606 $0.00 3,606 $16.15
Common Stock Stock Option (Right to Purchase) Disposition 2022-12-20 33,758 $0.00 33,758 $16.15
Common Stock Stock Option (Right to Purchase) Disposition 2022-12-21 46,600 $0.00 46,600 $16.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
105,399 2026-01-20 No 4 M Direct
71,641 2026-01-20 No 4 M Direct
25,041 2026-01-20 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.
  2. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).
  3. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
  4. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4).
  5. The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable.